Your browser doesn't support javascript.
loading
Mycophenolate mofetil therapy for two cases of antiphospholipid antibody-associated chorea.
Yokoyama, Koji; Mori, Masaaki; Yoshida, Akira.
Afiliación
  • Yokoyama K; a Department of Pediatrics , Japanese Red Cross Wakayama Medical Center , Wakayama , Japan and.
  • Mori M; b Department of Pharmacovigilance , Tokyo Medical and Dental University , Tokyo , Japan.
  • Yoshida A; a Department of Pediatrics , Japanese Red Cross Wakayama Medical Center , Wakayama , Japan and.
Mod Rheumatol ; 28(4): 709-711, 2018 Jul.
Article en En | MEDLINE | ID: mdl-26708652
ABSTRACT
Chorea is associated with involuntary movement and may occur via an autoimmune mechanism. Until now, we treated immune-mediated chorea with glucocorticoids and cyclophosphamide as the efficacy of mycophenolate mofetil (MMF) therapy for this condition was unknown. Here, we report two cases of antiphospholipid antibody (aPL)-associated chorea that were cured by MMF. Measurement of aPL could help for future management of chorea patients. This report provides new insight into the beneficial effects of MMF on aPL-associated chorea.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Corea / Inmunosupresores / Ácido Micofenólico Tipo de estudio: Risk_factors_studies Límite: Adolescent / Child / Female / Humans Idioma: En Revista: Mod Rheumatol Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Corea / Inmunosupresores / Ácido Micofenólico Tipo de estudio: Risk_factors_studies Límite: Adolescent / Child / Female / Humans Idioma: En Revista: Mod Rheumatol Año: 2018 Tipo del documento: Article